Divergent Requirements for EZH1 in Heart Development Versus Regeneration

Area of Science:

• Epigenetics
• Molecular Biology
• Cardiovascular Science

Background:

• Polycomb repressive complex 2 (PRC2) is a key epigenetic regulator controlling cell differentiation.
• EZH1 and EZH2 are catalytic subunits of PRC2 with overlapping functions.
• The specific roles of EZH1 and EZH2 in cardiac development and regeneration remain unclear.

Purpose of the Study:

• To investigate and compare the distinct roles of EZH1 and EZH2 in heart development and neonatal regeneration.
• To elucidate the underlying molecular mechanisms governing their functions in the heart.

Main Methods:

• Utilized knockout mouse models to ablate Ezh1 and Ezh2 genes in cardiac myocytes.
• Performed epigenome and transcriptome profiling to analyze gene expression changes.
• Conducted rescue experiments by re-expressing EZH1 or EZH2 in knockout models.
• Assessed cardiac function and myocyte proliferation following myocardial infarction.

Main Results:

• Complete ablation of both EZH1 and EZH2 led to lethal heart malformations during development.
• EZH1, but not EZH2, was essential for neonatal heart regeneration and functional recovery post-myocardial infarction.
• EZH1 directly regulates genes involved in cardiac growth and myocyte proliferation.

Conclusions:

• EZH1 has distinct and critical roles in heart development and regeneration, independent of EZH2.
• Understanding EZH1's mechanisms can help overcome epigenetic barriers to cardiac repair.
• Targeting EZH1 may offer therapeutic potential for heart regeneration.